• 1
    Bower JE. Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol. 2005; 23: 8280-8282.
  • 2
    Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005; 23: 6613-6622.
  • 3
    Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. Progress toward guidelines for the management of fatigue. Oncology (Williston Park). 1998; 12: 369-377.
  • 4
    National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Fort Washington, PA: NCCN; 2011.
  • 5
    Piper BF, Cella D. Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010; 8: 958-966.
  • 6
    Curt GA. Impact of fatigue on quality of life in oncology patients. Semin Hematol. 2000; 37: 14-17.
  • 7
    de Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM. Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol. 2004; 15: 896-905.
  • 8
    Clark EJ, Stovall EL, Leigh S, Siu AL, Austin DK, Rowland JH. Imperatives for Quality Cancer Care: Access, Advocacy, Action, and Accountability. Silver Spring, MD: National Coalition for Cancer Survivorship; 1996.
  • 9
    Taylor RM. Personalized cancer care. In: Lester JL, Schmitt P, eds. Cancer Rehabilitation and Survivorship. Pittsburgh, PA: Oncology Nursing Society; 2011: 3-5.
  • 10
    Gledhill J. A qualitative study of the characteristics and representation of fatigue in a French speaking population of cancer patients and healthy subjects. Eur J Oncol Nurs. 2005; 9: 294-312; discussion 313-314.
  • 11
    Stone PC, Minton O. Cancer-related fatigue. Eur J Cancer. 2008; 44: 1097-1104.
  • 12
    Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun. 2010; 24: 1209-1217.
  • 13
    Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry. 2006; 77: 34-39.
  • 14
    Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. 2006; 12: 2759-2766.
  • 15
    Karayiannakis AJ, Syrigos KN, Polychronidis A, Pitiakoudis M, Bounovas A, Simopoulos K. Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Res. 2001; 21: 1355-1358.
  • 16
    Harvey SB, Wessely S, Kuh D, Hotopf M. The relationship between fatigue and psychiatric disorders: evidence for the concept of neurasthenia. J Psychosom Res. 2009; 66: 445-454.
  • 17
    Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004; 4: 891-899.
  • 18
    Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006; 9: 425-434.
  • 19
    Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005; 307: 384-387.
  • 20
    Dalsgaard MK, Secher NH. The brain at work: a cerebral metabolic manifestation of central fatigue. J Neurosci Res. 2007; 85: 3334-3339.
  • 21
    Nair KS. Aging muscle. Am J Clin Nutr. 2005; 81: 953-963.
  • 22
    Yavuzsen T, Davis MP, Ranganathan VK, et al. Cancer-related fatigue: central or peripheral? J Pain Symptom Manage. 2009; 38: 587-596.
  • 23
    Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab. 2004; 286: E92-E101.
  • 24
    Mock V, Frangakis C, Davidson NE, et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology. 2005; 14: 464-477.
  • 25
    McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006; 175: 34-41.
  • 26
    Courneya KS. Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc. 2003; 35: 1846-1852.
  • 27
    Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002; 64: 604-611.
  • 28
    Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002; 20: 42-51.
  • 29
    Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006; 13: 279-292.
  • 30
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003; 348: 1625-1638.
  • 31
    Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010; 123: 627-635.
  • 32
    Rabin C, Pinto B, Dunsiger S, Nash J, Trask P. Exercise and relaxation intervention for breast cancer survivors: feasibility, acceptability and effects. Psychooncology. 2009; 18: 258-266.
  • 33
    Singh NA, Clements KM, Fiatarone MA. A randomized controlled trial of the effect of exercise on sleep. Sleep. 1997; 20: 95-101.
  • 34
    Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004; 350: 664-671.
  • 35
    Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care. 2001; 10: 245-255.
  • 36
    Berger AM, Farr LA, Kuhn BR, Fischer P, Agrawal S. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage. 2007; 33: 398-409.
  • 37
    Gerber LH, Stout N, McGarvey C, et al. Factors predicting clinically significant fatigue in women following treatment for primary breast cancer. Support Care Cancer. 2012; 19: 1581-1591.
  • 38
    Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008; 26: 768-777.
  • 39
    Alexander S, Minton O, Andrews P, Stone P. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer. 2009; 45: 384-392.
  • 40
    Janz NK, Mujahid M, Chung LK, et al. Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt). 2007; 16: 1348-1361.
  • 41
    Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis [serial online]. Oncol Nurs Forum. 2006; 33: E79-E89.
  • 42
    Demark-Wahnefried W, Campbell KL, Hayes SC. Weight management and its role in breast cancer rehabilitation. Cancer. 2012; 118( suppl 8): 2277-2287.
  • 43
    Hayes SC, Johansson K, Stout NL, et al. Upper-body morbidity following breast cancer: incidence and evidence for evaluation, prevention and management within a prospective surveillance model of rehabilitation. Cancer. 2012; 118( suppl 8): 2237-2249.
  • 44
    McNeely ML, Binkley JM, Pusic AL, et al. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues. Cancer. 2012; 118( suppl 8): 2226-2236.
  • 45
    Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR. Prospective surveillance and management of cardiovascular health in breast cancer survivors. Cancer. 2012; 118( suppl 8): 2270-2276.
  • 46
    Schmitz KH, Speck RM, Rye SA, DiSipio T, Hayes SC. Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study. Cancer. 2012; 118( suppl 8): 2217-2225.
  • 47
    Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy induced peripheral neuropathy. Cancer. 2012; 118( suppl 8): 2250-2260.
  • 48
    Winters-Stone KM, Schwartz AL, Hayes SC, Fabian CJ, Campbell KL. A prospective model of care for breast cancer rehabilitation: bone health and arthralgias. Cancer. 2012; 118( suppl 8): 2288-2299.
  • 49
    Yoon J, Malin JL, Tao ML, et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat. 2008; 108: 153-165.
  • 50
    Crandall C, Petersen L, Ganz PA, Greendale GA. Association of breast cancer and its therapy with menopause-related symptoms. Menopause. 2004; 11: 519-530.
  • 51
    Aksoy S, Dede DS, Yaman S, Ozkan C, Gullu IH, Altundag K. Sleep disturbance in patients with operable breast cancer receiving adjuvant hormone therapy [abstract]. J Clin Oncol. 2011; 29( suppl). Abstract e11125.
  • 52
    Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006; 106: 751-758.
  • 53
    Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008; 26: 3536-3542.
  • 54
    Hack TF, Kwan WB, Thomas-Maclean RL, et al. Predictors of arm morbidity following breast cancer surgery. Psychooncology. 2010; 19: 1205-1212.
  • 55
    Collins LG, Nash R, Round T, Newman B. Perceptions of upper-body problems during recovery from breast cancer treatment. Support Care Cancer. 2004; 12: 106-113.
  • 56
    Karki A, Simonen R, Malkia E, Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med. 2005; 37: 180-188.
  • 57
    Gartner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment—a nationwide study of prevalence and associated factors. Breast. 2010; 19: 506-515.
  • 58
    Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B. Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life [serial online]. Health Qual Life Outcomes. 2010; 8: 92.
  • 59
    Smoot B. Upper extremeity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010; 4: 167-178.
  • 60
    Nesvold IL, Reinertsen KV, Fossa SD, Dahl AA. The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv. 2011; 5: 62-72.
  • 61
    Vassard D, Olsen MH, Zinckernagel L, Vibe-Petersen J, Dalton SO, Johansen C. Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort study. Eur J Cancer. 2010; 46: 3211-3218.
  • 62
    Kris MG, Benowitz SI, Adams S, et al. Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2010; 28: 5327-5347.
  • 63
    Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D. Longitudinal prospective assessment of sleep disturbances in breast cancer [abstract]. J Clin Oncol. 2010; 28( 15s). Abstract 9101.
  • 64
    Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev. 2006; 10: 419-429.
  • 65
    Palesh OG, Roscoe JA, Mustian KM, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010; 28: 292-298.
  • 66
    Bennett BK, Goldstein D, Boyle FM, et al. What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study [abstract]. J Clin Oncol. 2011; 28( 15s). Abstract 605.
  • 67
    Rumble ME, Keefe FJ, Edinger JD, Affleck G, Marcom PK, Shaw HS. Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis. Sleep. 2010; 33: 1501-1509.
  • 68
    Lis CG, Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer. 2008; 16: 261-266.
  • 69
    Schultz SL, Dalton SO, Christensen J, Carlsen K, Ross L, Johansen C. Factors correlated with fatigue in breast cancer survivors undergoing a rehabilitation course, Denmark, 2002-2005. Psychooncology. 2011; 20: 352-360.
  • 70
    Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster [serial online]. Oncol Nurs Forum. 2005; 32: E48-E55.
  • 71
    Hegel MT, Moore CP, Collins ED, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer. 2006; 107: 2924-2931.
  • 72
    Mehnert K, Koch U. Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res. 2008; 64: 383-391.
  • 73
    Reich M, Lesur A, Perdrizet-Chevallier C. Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat. 2008; 110: 9-17.
  • 74
    Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000; 88: 653-663.
  • 75
    Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001; 285: 885-892.
  • 76
    Nagel G, Wedding U, Rohrig B, Katenkamp D. The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol. 2004; 130: 664-670.
  • 77
    Earle CC, Burstein HJ, Winer EP, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003; 21: 1447-1451.
  • 78
    Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ. Behavioral health services for women who have breast cancer. J Clin Oncol. 2009; 27: 706-712.
  • 79
    Snyder CF, Frick KD, Peairs KS, et al. Comparing care for breast cancer survivors to non-cancer controls: a 5-year longitudinal study. J Gen Intern Med. 2009; 24: 469-474.
  • 80
    Weinstein AA, Drinkard BM, Diao G, et al. Exploratory analysis of the relationships between aerobic capacity and self-reported fatigue in patients with rheumatoid arthritis, polymyositis, and chronic fatigue syndrome. PM R. 2009; 1: 620-628.
  • 81
    Wessely S, Powell R. Fatigue syndromes: a comparison of chronic “postviral” fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry. 1989; 52: 940-948.
  • 82
    Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol. 2009; 20: 17-25.
  • 83
    Jacobsen PB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004; 32: 93-97.
  • 84
    Whitehead L. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. J Pain Symptom Manage. 2009; 37: 107-128.
  • 85
    Piper BF, Borneman T, Sun VC, et al. Cancer-related fatigue: role of oncology nurses in translating national comprehensive cancer network assessment guidelines into practice. Clin J Oncol Nurs. 2008; 12: 37-47.
  • 86
    Mitchell SA, Beck SL, Eaton LH. Fatigue. In: Eaton LH, Tipton JM, eds. Putting Evidence into Practice. Pittsburgh, PA: Oncology Nursing Society; 2009: 149-174.
  • 87
    Berger AM, Bruera E, Cimprich B. Recognition and treatment of the symptom of cancer-related fatigue. In: American Society of Clinical Society, ed. ASCO 2010 Educational Book. Alexandria, VA: American Cancer Society; 2010: 350-355.
  • 88
    Brown JC, Huedo-Medina T, Pescatello LS, Pescatello SM, Ferrer RA, Johnson BT. Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011; 20: 123-133.
  • 89
    Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults [serial online]. Cochrane Database Syst Rev. 2008;( 2): CD006145.
  • 90
    Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults [serial online]. Cochrane Database Syst Rev. 2009; 91): CD006953.
  • 91
    Jacobsen P, Donovan K, Vadaparampil S, Small B. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007; 26: 660-667.
  • 92
    Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008; 134: 700-741.
  • 93
    Mitchell SA. Cancer-related fatigue: state of the science. PM R. 2010; 2: 364-383.
  • 94
    Mustian KM, Morrow GR, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist. 2007; 12( suppl 1): 52-67.
  • 95
    Scott JA, Lasch KE, Barsevick AM, Piault-Louis E. Patients' experiences with cancer-related fatigue: a review and synthesis of qualitative research [serial online]. Oncol Nurs Forum. 2011; 38: E191-E203.
  • 96
    Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010; 4: 87-100.
  • 97
    Spence RR, Heesch KC, Brown WJ. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev. 2010; 36: 185-194.
  • 98
    Velthuis MJ, Agasi-Idenburg S, Aufdemkampe G, Wittink HM. The effect of physical exercise on cancer-related fatigue during cancer treatment: a meta-analysis of randomised controlled trials. Clin Oncol (R Coll Radiol). 2010; 22: 208-221.
  • 99
    White SM, McAuley E, Estabrooks PA, Courneya KS. Translating physical activity interventions for breast cancer survivors into practice: an evaluation of randomized controlled trials. Ann Behav Med. 2009; 37: 10-19.
  • 100
    Wanchai A, Armer JM, Stewart BR. Nonpharmacologic supportive strategies to promote quality of life in patients experiencing cancer-related fatigue. Clin J Oncol Nurs. 2011; 15: 203-214.
  • 101
    Lowe SS, Watanabe SM, Baracos VE, Courneya KS. Physical activity interests and preferences in palliative cancer patients. Support Care Cancer. 2010; 18: 1469-1475.
  • 102
    Duijts SFA, Faber MM, Oldenburg HSA, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors—a meta-analysis. Psychooncology. 2011; 20: 115-126.
  • 103
    Markes M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer [serial online]. Cochrane Database Syst Rev. 2006;( 4): CD005001.
  • 104
    Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007; 25: 4396-4404.
  • 105
    Berger AM. Update on the state of the science: sleep-wake disturbances in adult patients with cancer [serial online]. Oncol Nurs Forum. 2009; 36: E165-E177.
  • 106
    Dirksen SR, Epstein DR. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs. 2008; 61: 664-675.
  • 107
    Epstein DR, Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors [serial online]. Oncol Nurs Forum. 2007; 34: E51-E59.
  • 108
    Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA. Randomized controlled clinical effectiveness trial of cognitive behavioral therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008; 26: 1-9.
  • 109
    Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol. 2005; 23: 6083-6096.
  • 110
    Goedendorp MM, Peters ME, Gielissen MF, et al. Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist. 2010; 15: 1122-1132.
  • 111
    Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. Drug therapy for the management of cancer-related fatigue [serial online]. Cochrane Database Syst Rev. 2010;( 7): CD006704.
  • 112
    Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care [serial online]. Cochrane Database Syst Rev. 2010;( 11): CD006788.
  • 113
    de la Cruz, Hui D, Parsons HA, Bruera E. Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer. 2010; 116: 766-774.
  • 114
    Stout NL, Andrews K, Binkley JM, Schmitz KH, Smith RA. Prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012; 118( suppl 8): 2191-2200.